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Aims 
   Endoscopic Ultrasound (EUS) plays an important role in the accurate staging of 
oesophageal adenocarcinoma (OAC) prior to neo-adjuvant chemotherapy (NAC) and 
surgical resection.  However, discrepancy can occur between the EUS and pathological  
tumour (T) and lymph node (LN) staging.  We sought to determine the accuracy of EUS 
staging and whether it correlated to a patient’s response to NAC. 
Methods 
   Clinical and pathological staging data was collected for 172 patients treated with 
cisplatin-based NAC followed by surgical resection at a single institution between 2004 
and 2012.  Tumour (T) and lymph node (N) stage was assessed at diagnosis 
radiologically (computed tomography, positron emission tomography, endoscopic 
ultrasonography) and then pathologically at resection.  EUS was performed on 160 (93%) 
of resectable OAC patients and reports for 127 cases (73.8%) were obtained for inclusion 
in this study.  All resection specimens were staged according to the TNM 7th edition 
classification and pathological response assessed according to the Mandard Tumour 
Regression Grade (TRG). 
Results 
   Following neo-adjuvant chemotherapy and surgical resection T stage was decreased in 
34 (26.8%), remained the same in 83 (65.4%) and increased in 10 (7.9%) of patients.  LN 
stage was available for 111 cases (64.5%) and decreased, stayed the same and 
increased in 28 (25.2%), 40 (36.0%) and 43 (38.7%) patients respectively.  Of those 
cases with an increase in LN stage following chemotherapy, 14 (32.6%) showed an 
increase in LN stage of 1 and 29 (67.4%) an increase of 2 TNM classes.  A high Mandard 
TRG was significantly associated with an increase in N stage following neo-adjuvant 
chemotherapy (p<0.001). 
Conclusions 
   Pre-operative staging by EUS tends to understage lymph node disease in OAC.  This 
effect may be partially corrected for by response to NAC but those tumours with a high 
TRG are associated with an increase in the LN stage between EUS and resection.   
    
 
